HOME >> MEDICINE >> NEWS
Serono receives FDA approval for Gonal-f RFF Pen to treat infertility

Geneva, Switzerland and Rockland, MA, May 27, 2004 -- Serono, Inc., the US affiliate of Serono (virt-x: SEO and NYSE: SRA), announced today that the United States Food and Drug Administration (FDA) has approved a prefilled device that delivers a new liquid formulation of the most prescribed gonadotropin in the world: Gonal-f RFF Pen (follitropin alfa injection).

Gonal-f RFF Pen is the first and only prefilled and ready-to-use multi-dose FSH (follicle stimulating hormone) in the US. It will be available in three sizes that deliver either 300 IU, 450 IU or 900 IU of liquid Gonal-f filled-by-mass, which can be administered in multiple doses. Developed to make infertility treatment easier, it provides patients with a new way to administer Gonal-f by simply dialing the correct dose without the need to mix medication or load cartridges. It was designed specifically for the treatment of infertility to allow patients to easily and accurately deliver a precise daily dose of medication.

"We are proud to be the first company to offer a prefilled and ready-to-use pen, providing a new option for infertility patients that is easy and simple to use, " said Bharat Tewarie, MD, Executive Vice President, Reproductive Health, Serono, Inc. "Serono is the world leader in reproductive health, and we are again demonstrating our commitment to continually improve the patient experience. Gonal-f RFF Pen, in addition to our multi-dose and single-dose vial presentations, gives us the most extensive and complete portfolio of infertility products to allow for enhanced dosing flexibility and individualized treatment." Serono expects Gonal-f RFF Pen to be available in the US in Q3 of this year.

Gonal-f RFF Pen is indicated for induction of ovulation and pregnancy in anovuluatory infertile women in whom the cause of infertility is functional and not due to primary ovarian failure. It is also indicated for the development of multiple follicles in ovulatory women part
'"/>

Contact: Aimee White
aimee.white@edelman.com
212-642-7767
Edelman Public Relations
27-May-2004


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... 11, 2019 , ... PatientPay, the leading end-to-end patient payment ... of a patent to reduce the level of effort a medical group must ... visit patient statements. , At the core of “Instant Integration for Installment Payments” ...
(Date:9/11/2019)... , ... September 11, 2019 , ... Executives at health ... of change in the healthcare industry over the past several years has been intense. ... worse. The future of healthcare in America will depend largely on how these executives ...
(Date:9/11/2019)... ... 2019 , ... Women’s Excellence is pleased to welcome Dr. ... highly skilled Obstetrician/Gynecologist. She approaches patients compassionately and offers comprehensive obstetrical and ... visit is comfortable, patient-focused, and that every patient feels her concerns have been ...
(Date:9/11/2019)... NEW YORK (PRWEB) , ... ... ... expertise of industry leaders to explore solutions to problems facing the ever-changing ... edition of their campaign, “Employee Benefits and Engagement.” With topics ranging from ...
(Date:9/11/2019)... , ... September 11, 2019 , ... Dimensional Insight®, ... the registration table at the annual St. Jude Walk/Run Boston. To be held on ... of participants to raise a goal of $650,000 for St. Jude Children’s Research ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... September 18, 2019 , ... U.S. Dermatology Partners was ... water swim Saturday, September 14th. The event took place at Lake Ray Hubbard ... and Jim Montgomery. The money raised helps fund phase 1 clinical trials ...
(Date:9/17/2019)... New Zealand (PRWEB) , ... September 17, 2019 , ... ... in in Fast Company’s 2019 Innovation by Design Awards Students category. , It was ... at the Auckland Bioengineering Institute. , Muss-Bits is comprised of two parts. A “sensor ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... proud to establish a new partnership with NextGen Healthcare Inc., a leading healthcare ... of partners, which include Nextech, DrChrono, Symplast and Azalea, with additional partnerships to ...
Breaking Medicine Technology:
Cached News: